Drugs / Estrogens, Conjugated (USP)
last change Jul 2016 re-read 3 minutes ago

Estrogens, Conjugated (USP)

Developed for
coronary atherosclerosis
Investigated by
Federal University of Minas Gerais · National Heart, Lung, and Blood Institute (NHLBI) · Tufts University

Trials 2

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/31 trial
Phase 2/3 NCT00083824 Mar 2004 → Feb 2007 coronary atherosclerosis Tufts University Completed No outcome recorded
Phase not applicable1 trial · 1 met primary
— NCT01482416 Nov 2011 → Aug 2014 — Federal University of Minas Gerais Completed Met primary

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Estrogens, Conjugated (USP) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00083824 ↗
1

NCT01482416 ↗

Known as CEE “Study participants were 256 women who completed the Estrogen Replacement and Atherosclerosis (ERA) trial, a placebo-controlled, randomized trial that examined the effects of...” PMID 19155011 ↗ Dec 2008
1

“the use of conjugated equine estrogens (CEE) or placebo” PMID 27427235 ↗ Jul 2016

Known as conjugated equine estrogen “Study participants were 256 women who completed the Estrogen Replacement and Atherosclerosis (ERA) trial, a placebo-controlled, randomized trial that examined the effects of...” PMID 19155011 ↗ Dec 2008
Known as conjugated equine estrogens “the use of conjugated equine estrogens (CEE) or placebo” PMID 27427235 ↗ Jul 2016